Dental Bone Graft Substitute Market Outlook (2022-2033)

Rising Demand for Dental Implants and Aging Population

The increasing global inclination towards dental procedures, especially dental implants, is one of the major reasons for the growth of the dental bone graft substitute market. This drift is associated with a fast-growing elderly population and is also influenced by people's general awareness of oral health. Recent industry reports suggest that dental implant procedures are the main reason for the majority of the bone grafts used, with about 68% of the grafts being implanted-related applications because clinicians look for effective regeneration solutions to support the success of the implants. Moreover, the WHO reports reveal that a considerable amount of the world's population has dental problems—about 2 billion adults suffer from caries and over 1 billion from periodontal diseases—which usually leads to the need for bone regeneration. The elderly population is another group demanding this greatly; they forecast that by 2030, the number of adults aged 60 years and above will reach 1.4 billion which means more cases of edentulism and bone loss that will need the dentist to perform a graft procedure. Taking all these factors into account, the clinical need for bone graft substitutes that are both reliable and biocompatible is growing across the whole world.

Technological Innovations and Product Developments

A solid technological innovation and product development are the best opportunities in the dental bone graft substitute market. Major companies are launching sophisticated graft materials that are designed for better clinical outcomes of the entire process. In the past few years, there have been a number of important developments: the Straumann Group came out with "NeoCera," a synthetic ceramic that has properties conducive to the adhesion of osteoblasts; Geistlich Biomaterials introduced "Bio-Oss Flex" that is malleable and easy to work with, and Zimmer Biomet Dental got the FDA’s green light for "RegenerOss Plus," a biphasic calcium phosphate graft embedding growth factor. Other strides include patient-specific bone scaffold solutions made via 3D printing—thanks to collaborations like Nobel Biocare and Desktop Health—which cut the time for surgeries and give better anatomical fit. Moreover, the launch of AI-assisted particle distribution products (e.g., MinerOss AI) and the emergence of injectable putty-form xenografts for niche procedures are further proof that the industry is going in the right direction, i.e., towards the development of more effective and user-friendly materials. This advancement in technology has the power not only to elevate the quality of treatment but also to open up new avenues for differentiation, and the expansion of the market and clinician acceptance on a global scale.

The " Dental Bone Graft Substitute Market Size and Forecast (2022 - 2033)" report provides a detailed analysis of the market covering below areas:

• Dental bone graft substitute market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Dental bone graft substitute market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Dental bone graft substitute market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the dental bone graft substitute market
• Detailed company profiles, including SWOT analysis

The geographical scope of the dental bone graft substitute market report is divided into five regions: North America, Asia Pacific, Europe, Middle East and Africa, and South and Central America. The dental bone graft substitute market in Asia Pacific is expected to grow significantly during the forecast period.

The Asia-Pacific dental bone graft substitute market is segmented into China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh, and the Rest of Asia. The Asia-Pacific dental bone graft substitute market is experiencing robust growth, due to a mixture of demographic, economic, and healthcare system factors. The large and rapidly aging population in countries like China, Japan, and South Korea leads to a higher incidence of tooth loss, periodontal disease, and jawbone degeneration. Hence, there is growth in the demand for bone regeneration procedures. The rising disposable incomes and empires of the middle-class population are the main reasons behind the high investments in advanced dental treatments including the implants which require bone graft substitutes.

Besides, the whole Asia-Pacific region is receiving enormous dental tourists every year due to the massive difference in the cost of good quality implant and grafting procedures between countries like India, Thailand, and Malaysia and the Western countries. Urbanization and the upgrading of the healthcare infrastructure have brought about the setting up of dental clinics with state-of-the-art implantology and regenerative technologies. Also, people's awareness of dental health and cosmetic dentistry supported by the government oral healthcare programs and the private sector's investments are leading to the promotion of treatment at an early stage and preventive care. Local companies are producing affordable and region-specific synthetic and xenograft products, thus, making them accessible and acceptable. In addition, a higher number of dental professionals who are trained and the use of digital dentistry and guided bone regeneration techniques are together resulting in the success of the procedures, thus, accelerating market growth in the whole Asia-Pacific region.

• The report includes qualitative and quantitative data in the dental bone graft substitute market across type, application, end-user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the dental bone graft substitute market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the dental bone graft substitute market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the dental bone graft substitute market scenario, in terms of historical market revenues, and forecast till the year 2031.
• Chapters 7 to 10 cover dental bone graft substitute market segments by type, application, end-user, and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. They cover the market revenue forecast and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the dental bone graft substitute market. Companies have been profiled on the basis of their key facts, business descriptions, products and services, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The dental bone graft substitute market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the dental bone graft substitute market are:

• In January 2023, Nobel Biocare in cooperation with Mimetis Biomaterials S.L. has introduced creos syntogain, a bone graft substitute biomimetic. This product catches more than just the attention of the stakeholders; it signifies the strategic shift at the whole face of the business that is already being processing through the plan of conducive change under the creos brand that includes the launches and others.
• In September 2024, NovaBone Products, a company that has a prominent position in the area of synthetic bone graft technology, made the announcement regarding their new MIS Delivery System with Tip. This system is introduced as the one to greatly increase the ability and dependability of the surgeons in the transferring of bone graft substitutes, especially those which are made for minimally invasive surgical (MIS) procedures.